SAFETY AND IMMUNOGENICITY OF A PHH-1V BOOSTER DOSE AFTER DIFFERENT PRIME VACCINATION SCHEMES AGAINST COVID-19: PHASE III CLINICAL TRIAL FINAL RESULTS UP TO ONE YEAR
View ORCID ProfileSilvina Natalini Martínez, Rafael Ramos, Jorge Navarro-Perez, View ORCID ProfileMaria Jesus Lopez, View ORCID ProfileMaria del Mar Vazquez, View ORCID ProfileJose Molto, View ORCID ProfilePatricia Munoz, View ORCID ProfileJose M Echave, View ORCID ProfileJose R Arribas, Melchor Alvarez, View ORCID ProfileEunate Arana-Arri, Jordi Calls, View ORCID ProfileSusana Otero-Romero, Francesco Scaglione, View ORCID ProfileLaia Bernad, Raúl Pérez-Caballero, View ORCID ProfileJulia G Prado, Ignasi Esteban, Elena Aurrecoechea, Roc Pomarol, View ORCID ProfileMontserrat Plana, View ORCID ProfileAlex Soriano
doi: https://doi.org/10.1101/2024.05.14.24307343
Silvina Natalini Martínez
1Unidad de Investigación de Vacunas, Instituto de Investigación Sanitaria HM, Madrid, Spain
Rafael Ramos
2Institut Universitari d’Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Biomedical Research Institute, Girona (IdIBGi), Catalan Institute of Health, Catalonia, Spain;
3Department of Medical Sciences, School of Medicine, University of Girona, Girona, Spain;
Jorge Navarro-Perez
4Hospital Clínico Universitario Valencia, Valencia, Spain;
Maria Jesus Lopez
5Preventive Medicine Unit, Hospital Regional Universitario de Málaga, Málaga, Spain;
Maria del Mar Vazquez
5Preventive Medicine Unit, Hospital Regional Universitario de Málaga, Málaga, Spain;
Jose Molto
6CIBER Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain;
7Fundació Lluita contra les Infeccions. Department of Infectious Diseases. Hospital Universitari Germans Trias i Pujol, Badalona, Spain;
Patricia Munoz
8Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain;
9Instituto de Investigación Sanitaria Hospital Gregorio Marañón, Madrid, Spain;
10CIBER Enfermedades Respiratorias-CIBERES (CB06/06/0058), Madrid Spain;
Jose M Echave
11Hospital Universitario Quironsalud, Madrid, Spain;
Jose R Arribas
6CIBER Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain;
12Infectious Diseases Unit, Internal Medicine Department, La Paz University Hospital, IdiPAZ, Madrid, Spain;
Melchor Alvarez
13Hospital Universitario Príncipe de Asturias, Madrid, Spain;
Eunate Arana-Arri
14Scientific Coordination, Biocruces Bizkaia HRI, Osakidetza, Barakaldo, Spain;
Jordi Calls
15Hospital de Mollet, Mollet, Spain;
Susana Otero-Romero
16Preventive Medicine and Epidemiology Department, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain;
17Multiple Sclerosis Centre of Catalonia, Department of Neurology/Neuroimmunology, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain;
Francesco Scaglione
18ASST Great Metropolitan Niguarda, Milano, Italy;
Laia Bernad
19IrsiCaixa AIDS, Can Ruti Campus, Badalona, Spain;
20Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain;
Raúl Pérez-Caballero
19IrsiCaixa AIDS, Can Ruti Campus, Badalona, Spain;
20Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain;
Julia G Prado
6CIBER Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain;
19IrsiCaixa AIDS, Can Ruti Campus, Badalona, Spain;
20Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain;
Ignasi Esteban
21AIDS Research Group, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain;
Elena Aurrecoechea
21AIDS Research Group, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain;
Roc Pomarol
21AIDS Research Group, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain;
Montserrat Plana
6CIBER Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain;
21AIDS Research Group, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain;
Alex Soriano
6CIBER Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain;
22Hospital Clínic of Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
Article usage
Posted May 14, 2024.
SAFETY AND IMMUNOGENICITY OF A PHH-1V BOOSTER DOSE AFTER DIFFERENT PRIME VACCINATION SCHEMES AGAINST COVID-19: PHASE III CLINICAL TRIAL FINAL RESULTS UP TO ONE YEAR
Silvina Natalini Martínez, Rafael Ramos, Jorge Navarro-Perez, Maria Jesus Lopez, Maria del Mar Vazquez, Jose Molto, Patricia Munoz, Jose M Echave, Jose R Arribas, Melchor Alvarez, Eunate Arana-Arri, Jordi Calls, Susana Otero-Romero, Francesco Scaglione, Laia Bernad, Raúl Pérez-Caballero, Julia G Prado, Ignasi Esteban, Elena Aurrecoechea, Roc Pomarol, Montserrat Plana, Alex Soriano
medRxiv 2024.05.14.24307343; doi: https://doi.org/10.1101/2024.05.14.24307343
SAFETY AND IMMUNOGENICITY OF A PHH-1V BOOSTER DOSE AFTER DIFFERENT PRIME VACCINATION SCHEMES AGAINST COVID-19: PHASE III CLINICAL TRIAL FINAL RESULTS UP TO ONE YEAR
Silvina Natalini Martínez, Rafael Ramos, Jorge Navarro-Perez, Maria Jesus Lopez, Maria del Mar Vazquez, Jose Molto, Patricia Munoz, Jose M Echave, Jose R Arribas, Melchor Alvarez, Eunate Arana-Arri, Jordi Calls, Susana Otero-Romero, Francesco Scaglione, Laia Bernad, Raúl Pérez-Caballero, Julia G Prado, Ignasi Esteban, Elena Aurrecoechea, Roc Pomarol, Montserrat Plana, Alex Soriano
medRxiv 2024.05.14.24307343; doi: https://doi.org/10.1101/2024.05.14.24307343
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (196)
- Cardiovascular Medicine (2877)
- Dermatology (245)
- Emergency Medicine (432)
- Epidemiology (12603)
- Forensic Medicine (10)
- Gastroenterology (811)
- Genetic and Genomic Medicine (4476)
- Geriatric Medicine (407)
- Health Economics (717)
- Health Informatics (2867)
- Health Policy (1057)
- Hematology (378)
- HIV/AIDS (907)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (465)
- Neurology (4233)
- Nursing (226)
- Nutrition (619)
- Oncology (2218)
- Ophthalmology (630)
- Orthopedics (255)
- Otolaryngology (322)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (489)
- Pediatrics (1182)
- Primary Care Research (485)
- Public and Global Health (6818)
- Radiology and Imaging (1502)
- Respiratory Medicine (907)
- Rheumatology (430)
- Sports Medicine (373)
- Surgery (475)
- Toxicology (59)
- Transplantation (204)
- Urology (175)